Showing results (11-20 of 32) with videos related to

Sort By:
Pageof 4
Clinica Chimica Acta; International Journal of Clinical Chemistry|March 10, 2017
Matrix effect-corrected liquid chromatography/tandem mass-spectrometric method for determining acylcarnitines in human urineKazuki Abe, Hiroyuki Suzuki, Masamitsu Maekawa, et al.
JSES International|December 29, 2025
Preoperative pain associated with rotator cuff tears correlates with synovitis severity in the rotator intervalYuichi Nagase, Kazuki Abe, Kazuya Tamai, et al.
Oncology Letters|May 9, 2020
Prognostic value of quantitative FDG-PET in the prediction of survival and local recurrence for patients with advanced oral cancer treated with superselective intra-arterial chemoradiotherapyTomoyuki Oyama, Yoichiro Hosokawa, Kazuki Abe, et al.
Inflammation Research : Official Journal of the European Histamine Research Society ... [Et Al.]|April 1, 2009
Hepatic protection by glycyrrhizin and inhibition of iNOS expression in concanavalin A-induced liver injury in miceNoriko Tsuruoka, Kazuki Abe, Kenjirou Wake, et al.
Internal Medicine (Tokyo, Japan)|November 19, 2023
Successful Treatment of Primary Mediastinal Large B-cell Lymphoma with DA-EPOCH-Rituximab Therapy in a Transgender WomanSanshiro Nakao, Sho Tanaka, Kazuki Abe, et al.
Toxicon : Official Journal of the International Society on Toxinology|June 24, 2005
Amino acid sequence of a basic aspartate-49-phospholipase A2 from Trimeresurus flavoviridis venom and phylogenetic analysis of Crotalinae venom phospholipases A2Takahito Chijiwa, Kazuki Abe, Tomohisa Ogawa, et al.
Archives of Histology and Cytology|February 6, 2009
The inhibition of apoptosis by glycyrrhizin in hepatic injury induced by injection of lipopolysaccharide / D-galactosamine in miceTadayuki Ikeda, Kazuki Abe, Noriyuki Kuroda, et al.
European Journal of Pharmacology|September 11, 2007
Inhibitory effect of glycyrrhizin on lipopolysaccharide and d-galactosamine-induced mouse liver injuryTsuyoshi Yoshida, Kazuki Abe, Tadayuki Ikeda, et al.
Clinical Nephrology|June 2, 2025
Angiotensin receptor-neprilysin inhibitor in the management of heart failure in patients with an episode of malignant hypertension and advanced kidney dysfunction: A case series and literature reviewTomohiro Saito, Masahide Mizobuchi, Mitsuru Kawanishi, et al.
European Journal of Clinical Pharmacology|August 19, 2021
Impacts of cachexia progression in addition to serum IgG and blood lymphocytes on serum nivolumab in advanced cancer patientsKazuki Abe, Kaito Shibata, Takafumi Naito, et al.
Pageof 4